Neuronetics, Inc. (NASDAQ:STIM) disclosed that its President and Chief Executive Officer, Keith J. Sullivan, sold 33,847 shares of the company's common stock on February 12, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The trades generated $55,847 in proceeds and were executed at weighted average prices between $1.56 and $1.72 per share.
Following the disposition, the filing shows Sullivan continues to directly own 1,533,165 shares of Neuronetics common stock. Company filings state the share sale was made to meet tax obligations arising from the vesting of restricted stock units held by Sullivan.
In parallel to the insider transaction, Neuronetics released preliminary unaudited financial results that indicate marked revenue expansion in 2025. The company reported fourth-quarter 2025 revenue of $41.8 million, an increase of 86% versus the prior-year quarter. For the full year, preliminary figures show total revenue of $149.2 million, representing a 99% rise compared with 2024. The company characterized these figures as both as reported and adjusted pro forma growth measures.
The firm's Compensation Committee also approved incentive awards for two executive officers. Steven E. Pfanstiel, the Executive Vice President, Chief Financial Officer, and Treasurer, was granted a cash award of $240,000 together with 170,212 restricted stock units. W. Andrew Macan, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary, received a cash award of $231,750 and 164,361 restricted stock units.
These disclosures combine an insider sale tied explicitly to tax liabilities from vested RSUs with preliminary financial results and recent executive compensation decisions. The Form 4 filing documents the specific transaction details, while the company-provided preliminary revenue metrics and Compensation Committee actions outline recent corporate developments.